– Complement activation induces excessive T cell cytotoxicity in severe COVID-19
– Human genetic and immunological determinants of critical COVID-19 pneumonia
– A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
– In rare cases, coronavirus vaccines may cause Long Covid–like symptoms
– Most Anti-PF4 Antibodies in Vaccine-induced Immune Thrombotic Thrombocytopenia are transient
– Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency
– Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
En la sección: Autoinmunidad, COVID-19, Infectología, Inmunodeficiencias, Linfocitos T, Vacunología. Publicado en: . 
– Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
– Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae
– Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
– COVID-19 Vaccination and Cancer Patients, Clinical Recommendations
En la sección: COVID-19, Infectología, Vacunología. Publicado en: .
A pesar del alto número de mutaciones, ómicron conserva epítopes que están presentes en las vacunas cubanas Abdala y Soberanas, por lo que las dosis de refuerzo aportan inmunidad frente a la nueva cepa. Así se reporta en Serrano-Barrera O, Bello-Rodríguez M, Pupo-Rodríguez O, Robinson-Agramonte M, Pérez O. Variantes ómicron y delta de SARS-CoV-2 conservan epítopes presentes en vacunas cubanas anti-covid-19 Abdala y Soberana. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta 2022;47(1).
En la sección: COVID-19, Infectología, Inmunoinformática, Vacunología. Publicado en: .
– Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans
– T cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients
– Innate immunological pathways in COVID-19 pathogenesis
– Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection
– SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
– Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
– Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
– Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
En la sección: Artículos de revisión, Autoinmunidad, COVID-19, Infectología, Inmunidad innata, Inmunodeficiencias, Linfocitos T. Publicado en: .
– Rodríguez-Álvarez Y, Batista-Roche LG, Llopiz-Arzuaga A, Puente-Pérez P, Martínez-Castillo R, Castro-Velazco J, et al. Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15. BMC Immunol. 2021 Dec 18;22(1):79.
– Blanco OR, Dorta D, Hernández CA, Abreu D, Domínguez AG, Luna Y, et al. Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials. J Immunol Methods. 2022 Jan;500:113195.
En la sección: Autores cubanos en revistas extranjeras, COVID-19, Infectología, Vacunología. Publicado en: .
